Cancer

MHRA approves trofolastat for prostate cancer imaging

In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.

NHS budgets must be reviewed to tackle the cancer backlog

Dee Mathieson, Managing Director at Elekta Ltd, believes that NHS budgets need to directly address the cancer backlog - which remains the second largest cause of death, globally.

Apoptosis: A key alternate trigger of carcinogenesis

Chanda Siddoo-Atwal, President and Primary Biochemist of Moondust Cosmetics Ltd., explores apoptosis, a key alternate trigger of carcinogenesis.

The EU needs a new Marshall Plan for oncology

Małgorzata Anna Bogusz, Rapporteur of the EESC opinion SOC/677 – Europe’s beating cancer plan, argues here that the EU needs a new Marshall Plan for oncology.

Keto diet risk to pregnant women and kidney disease patients

New analysis of ketogenic (keto) diets discovers health risks, including cancer, to pregnant women and patients with kidney disease.

Antibiotics effective in treating melanoma

Researchers at KU Leuven have discovered that certain antibiotics appear to be effective in treating a form of skin cancer known as melanoma.

Simple test for early detection of oesophageal cancer is being rolled out in Scotland

A non-invasive test for the early detection of oesophageal cancer has been developed by a team of researchers at the Medical Research Council (MRC) Cancer Cell Unit and is now being rolled out across Scotland.

Screening frequently misses endometrial cancer in Black women

TVUS screening missed over four times more cases of endometrial cancer among Black women versus White women, according to a new study.

Biobanks to support medical research focus

With the current focus on public health worldwide, Arthur Goudena, Marketing Manager of PHC Europe, explains how one of Europe’s leading biobanks plays a growing role in supporting medical research.

Study reveals 94% of cancer patients react well to COVID vaccine

According to the US and Swiss study, 94% of cancer patients took the COVID vaccine in full and produced antibodies - while seven high-risk patients failed to produce an immune response.

Resourceful solid-state nanopores: From blue energy production to big data processing

Jean-Pierre Leburton, and Olgica Milenkovic, Professors of Electrical and Computer Engineering at the University of Illinois at Urbana-Champaign, discuss how big data processing via bio-sensing, and blue energy production revolutionise solid-state nanopores.

EU4Health: Building healthcare systems of tomorrow

European Commission Director General for Health and Food Safety Sandra Gallina details the ambitious EU4Health Programme proposed as a response to COVID-19.

New technologies for knowledge translation in cancer

Ahmed Samir Abdelhafiz and Zisis Kozlakidis both shed light on new technologies for knowledge translation in cancer.

53% of cancer patients are experiencing loneliness during the pandemic

According to a new study, more than half (53%) of adult cancer patients have been experiencing loneliness during the COVID-19 pandemic.

Only 16% of men received HPV vaccine

Researchers from Michigan Medicine have found that only 16% of men had received at least one dose of the HPV vaccine.

Mushroom consumption lowers the risk of cancer by 45%

Higher mushroom consumption is associated with a 45% lower risk of cancer, according to a new Penn State study.

Improving cancer treatment and services during and beyond COVID-19

Greg Quinn, BD UK, explores how cancer treatment and services have been impacted by the pandemic and the potential role of medical technology in supporting the NHS during this complex time.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders